A., Shaikh, F., Bhakat, S., Radadiya, A., Bhaskar, L
Here is the frustrating reality of the medical system: Mounjaro (tirzepatide) is currently FDA-approved only for the treatment of Type 2 Diabetes
In the past, Ive had to buffer retinols by layering them over moisturizer so I dont start flaking, peeling, and turning red
The patients on Tirzepatide experienced a notable reduction in waist circumference and a decrease in visceral fat percentage, which contributed to improved metabolic health and a lower risk of obesity-related diseases
Your first-month summary should include Medication name and dose Dose dates and times Any late or missed doses Injection sites used Weight trend (and body composition if measured) Top side effects with severity and timing Constipation or diarrhea pattern Protein, fiber, and water averages Foods that consistently helped or hurt Resistance-training and walking sessions completed Energy, sleep, mood concerns Questions you want answered Labs and screens to ask about at follow-up A1C and fasting glucose (if diabetic or prediabetic) Lipid panel Liver enzymes and kidney function Body composition recheck (DEXA or InBody) if available Iron, B12, vitamin D especially if you notice fatigue or hair shedding Mental health check-in note any persistent or severe changes in mood, sleep, or anxiety Whether to step the dose up, hold, or pause That is the value of first-month tracking: fewer vague memories, better clinician conversations, and more confidence in what changed
